July 30, 2016 2:35 AM ET


Company Overview of Intra-Cellular Therapies, Inc.

Key Executives for Intra-Cellular Therapies, Inc.

NameBoard RelationshipsTitleAge
Sharon Mates Ph.D.113 RelationshipsCo-Founder, Chairman, Chief Executive Officer and President63
Allen A. Fienberg Ph.D.No RelationshipsCo-Founder and Vice President of Business Development56
Paul Greengard Ph.D.83 RelationshipsCo-Founder and Chairman of Scientific Advisory Board--
Lawrence J. Hineline CPANo RelationshipsChief Financial Officer, Vice President of Finance, Treasurer and Assistant Secretary60
Robert E. Davis Ph.D.No RelationshipsChief Scientific Officer and Senior Vice President65
View More Key Executives

Intra-Cellular Therapies, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sharon Mates Ph.D. 113 RelationshipsIntra-Cellular Therapies, Inc.63
Paul Greengard Ph.D. 83 RelationshipsIntra-Cellular Therapies, Inc.--
Joel S. Marcus J.D., CPA 261 RelationshipsAlexandria Real Estate Equities, Inc.69
Christopher D. Alafi Ph.D. 15 RelationshipsAlafi Capital Company LLC53
Carol A. Tamminga M.D. 41 RelationshipsACADIA Pharmaceuticals Inc.--
View All Board Members

Intra-Cellular Therapies, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee BSRobert L. Van Nostrand40 Relationships2 Executives
Compensation Committee J.D., CPAJoel S. Marcus261 Relationships3 Executives
Nominating Committee Ph.D.Christopher D. Alafi15 Relationships2 Executives
Corporate Governance Committee Ph.D.Christopher D. Alafi15 Relationships2 Executives
Advisory Board M.D.Carol A. Tamminga41 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation$33.1M
Not meaningful
Total Value of Options$1.4M
Compensation as of Fiscal Year 2015
Intra-Cellular Therapies, Inc. CEO Compensation
Industry Average


Benchmark Holdings plc Announces Directorate Changes
July 29, 2016 6:00 AM ET
Valeant Pharmaceuticals International, Inc. Appoints Sarah B. Kavanagh as Director of the Board
July 28, 2016 9:00 PM ET
Agile Therapeutics, Inc. Announces Board Changes
July 28, 2016 8:30 PM ET
Novartis India Ltd. Announces Resignation of Girish Tekchandani as Company Secretary & Compliance Officer, Effective August 12, 2016
July 28, 2016 9:29 AM ET
RPG Life Sciences Limited Appoints Mr. Yugal Sikri as an Additional Director
July 28, 2016 8:47 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intra-Cellular Therapies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.